Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00330577
Status:
COMPLETED
Last Update Posted:
2014-05-12
First Post:
2006-05-26
Brief Title:
24-Hour Intraocular Pressure IOP And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
Sponsor:
Aristotle University Of Thessaloniki
Organization:
Aristotle University Of Thessaloniki
Study Overview
Official Title:
24-Hour Intraocular Pressure IOP And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control 24-hour blood pressure effect and safety of LatanoprostTimolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 05 given twice daily in patients with ocular hypertension and primary open-angle glaucoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None